Craig R Stapleton - Net Worth and Insider Trading
Craig R Stapleton Net Worth
The estimated net worth of Craig R Stapleton is at least $14 Million dollars as of 2024-11-13. Craig R Stapleton is the Director of Abercrombie & Fitch Co and owns about 57,398 shares of Abercrombie & Fitch Co (ANF) stock worth over $8 Million. Craig R Stapleton is also the Director of Avadel Pharmaceuticals PLC and owns about 503,413 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $6 Million. Details can be seen in Craig R Stapleton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig R Stapleton has not made any transactions after 2017-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig R Stapleton
Craig R Stapleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig R Stapleton owns 4 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Abercrombie & Fitch Co (ANF) , and Reata Pharmaceuticals Inc (RETA) among others .
Click here to see the complete history of Craig R Stapleton’s form 4 insider trades.
Insider Ownership Summary of Craig R Stapleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2017-12-15 | director |
| ANF | Abercrombie & Fitch Co | 2016-09-01 | director |
| RETA | Reata Pharmaceuticals Inc | 2016-06-01 | 10 percent owner |
 | | 2004-07-28 | director |
Craig R Stapleton Latest Holdings Summary
Craig R Stapleton currently owns a total of 2 stocks. Among these stocks, Craig R Stapleton owns 57,398 shares of Abercrombie & Fitch Co (ANF) as of September 1, 2016, with a value of $8 Million and a weighting of 57.29%. Craig R Stapleton also owns 503,413 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 15, 2017, with a value of $6 Million and a weighting of 42.71%.
Latest Holdings of Craig R Stapleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANF | Abercrombie & Fitch Co | 2016-09-01 | 57,398 | 143.72 | 8,249,241 |
| AVDL | Avadel Pharmaceuticals PLC | 2017-12-15 | 503,413 | 12.22 | 6,149,190 |
Holding Weightings of Craig R Stapleton
Craig R Stapleton Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig R Stapleton has made a total of 0 transactions in Abercrombie & Fitch Co (ANF) over the past 5 years. The most-recent trade in Abercrombie & Fitch Co is the acquisition of 10,000 shares on September 1, 2016, which cost Craig R Stapleton around $176,500.
According to the SEC Form 4 filings, Craig R Stapleton has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 140,000 shares on December 15, 2017, which cost Craig R Stapleton around $1 Million.
Insider Trading History of Craig R Stapleton
- 1
Craig R Stapleton Trading Performance
GuruFocus tracks the stock performance after each of Craig R Stapleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig R Stapleton is -2.29%. GuruFocus also compares Craig R Stapleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig R Stapleton within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig R Stapleton's insider trading performs compared to the benchmark.
Performance of Craig R Stapleton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.04 | | | | | |
| Relative Return to S&P 500(%) | 1.01 | | | | | |
Craig R Stapleton Ownership Network
Ownership Network List of Craig R Stapleton
Ownership Network Relation of Craig R Stapleton
Craig R Stapleton Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Craig R Stapleton is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Craig R Stapleton made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Craig R Stapleton Mailing Address
Above is the net worth, insider trading, and ownership report for Craig R Stapleton. You might contact Craig R Stapleton via mailing address: 55 Old Field Point Road, Suite 2, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
